Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 4/20 | 0.44 |
| ▸ | ENO1 | P06733 | 2/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360776 | 0.77 | FAAH (0.40) | FAAHNOS1NOS2MEN1ALDH1A1 | |
| SCHEMBL1645972 | 0.77 | FAAH (0.40) | CYP3A4FAAHNOS1NOS2MEN1 | |
| SCHEMBL5597540 | 0.77 | FAAH (0.51) | FAAHNOS1NOS2MEN1ALDH1A1 | |
| SCHEMBL26361631 | 0.76 | FAAH (0.39) | CYP3A4MAPTFAAHNOS1NOS2 | |
| SCHEMBL8026457 | 0.74 | — | — | |
| SCHEMBL1524639 | 0.74 | — | — | |
| SCHEMBL8734175 | 0.72 | FAAH (0.40) | TSHRFAAHNOS1NOS2MEN1 | |
| SCHEMBL24829876 | 0.70 | FAAH (0.41) | FAAHNOS1NOS2MEN1ALDH1A1 | |
| SCHEMBL18093606 | 0.70 | NOS1 (0.41) | FAAHNOS1NOS2MEN1ALDH1A1 | |
| SCHEMBL29076626 | 0.70 | NOS1 (0.41) | FAAHNOS1NOS2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230113775-A1 | ANHYDROUS COMPOSITIONS OF EGFR INHIBITORS AND METHODS OF USE | PALVELLA THERAPEUTICS, INC. (US) | 2023-04-13 | — | — | US | claimed |
| US-20150133543-A1 | TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2015-05-14 | — | — | US | claimed |
| EP-2858629-A1 | A TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | Leo Laboratories Limited (IE) | 2015-04-15 | — | — | EP | claimed |
| US-20140350120-A1 | TOPICAL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND AN OILY SOLVENT | LEO LABORATORIES LIMITED (IE) | 2014-11-27 | — | — | US | claimed |
| US-20140343141-A1 | TOPICAL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SURFACTANT-COSOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2014-11-20 | — | — | US | claimed |
| EP-2790694-A1 | A TOPICAL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SURFACTANT-COSOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2014-10-22 | — | — | EP | claimed |
| EP-2790669-A1 | A TOPICAL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND AN OILY SOLVENT | LEO LABORATORIES LIMITED (IE) | 2014-10-22 | — | — | EP | claimed |
| WO-2014128564-A2 | PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORS | DR. REDDY'S LABORATORIES LTD. (IN) | 2014-08-28 | — | — | WO | claimed |
| EP-2515866-B1 | PHARMACEUTICAL COMPOSITION COMPRISING SOLVENT MIXTURE AND A VITAMIN D DERIVATIVE OR ANALOGUE | LEO PHARMA AS (DK) | 2014-02-19 | — | — | EP | claimed |
| WO-2013182688-A1 | A TOPICAL GEL COMPOSITION COMPRISING AN INGENOL DERIVATIVE AND A SOLVENT MIXTURE | LEO LABORATORIES LIMITED (IE) | 2013-12-12 | — | — | WO | claimed |
| US-20020032171-A1 | Solubilization of triglycerides, drug delivery | LIPOCINE, INC. | 2002-03-14 | — | — | US | claimed |
| US-20020012680-A1 | Compositions and methods for improved delivery of lipid regulating agents | LIPOCINE INC. | 2002-01-31 | — | — | US | claimed |
| EP-1165048-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF IONIZABLE HYDROPHOBIC THERAPEUTIC AGENTS | Lipocine, Inc. (US) | 2002-01-02 | — | — | EP | claimed |
| EP-1158959-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF HYDROPHOBIC THERAPEUTIC AGENTS | Lipocine, Inc. (US) | 2001-12-05 | — | — | EP | claimed |
| US-6294192-B1 | PHARMACEUTICAL COMPOSITIONS CAPABLE OF SOLUBILIZING THERAPEUTICALLY EFFECTIVE AMOUNTS OF HYDROPHOBIC THERAPEUTIC AGENTS. CARRIER INCLUDES A HYDROPHILIC SURFACTANT AND A HYDROPHOBIC SURFACTANT, AQUEOUS DISPERSION | LIPOCINE, INC. | 2001-09-25 | — | — | US | claimed |
| US-6267985-B1 | COMPOSITION COMPRISING TRIGLYCERIDE, CARRIER COMPRISING AT LEAST TWO SURFACTANTS, AT LEAST ONE BEING HYDROPHILIC, THERAPEUTIC AGENT CAPABLE OF BEING SOLUBILIZED IN TRIGLYCERIDE AND/OR CARRIER; FORMS CLEAR AQUEOUS DISPERSION | LIPOCINE INC. | 2001-07-31 | — | — | US | claimed |
| WO-2001001960-A1 | CLEAR OIL-CONTAINING PHARMACEUTICAL COMPOSITIONS | LIPOCINE, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| WO-2000059475-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF IONIZABLE HYDROPHOBIC THERAPEUTIC AGENTS | LIPOCINE, INC. (US) | 2000-10-12 | — | — | WO | claimed |
| WO-2000050007-A1 | COMPOSITIONS AND METHODS FOR IMPROVED DELIVERY OF HYDROPHOBIC THERAPEUTIC AGENTS | LIPOCINE, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1023837-A2 | Non-aqueous, emulsifiable concentrate formulation | American Cyanamid Company (US) | 2000-08-02 | — | — | EP | claimed |